Zhejiang Bamboo Pharmaceuticals Co.,Ltd is an API manufacturer based in China. It holds 6 active US drug master files across a filed portfolio of 5 molecules. Its GMP standing is certified by US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 27 September 2024 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Shaoxing, China | Not on file |
| China, China | 3019684157 |
| Molecule | Regulators | Docs |
|---|---|---|
| Pregabalin | US FDA | 2 |
| Benzocaine | US FDA | 1 |
| Gabapentin | US FDA | 1 |
| Levocarnitine | US FDA | 1 |
| Tranexamic Acid | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 1 |
| EMA | None | 1 |
Choose your molecules and target markets. Zhejiang Bamboo Pharmaceuticals Co.,Ltd comes back tiered against every other supplier able to file there.
Start for free